Patent application number | Description | Published |
20090068266 | SIROLIMUS HAVING SPECIFIC PARTICLE SIZE AND PHARMACEUTICAL COMPOSITIONS THEREOF - Sirolimus particles having d | 03-12-2009 |
20090071855 | PACKAGING FOR AMORPHOUS STATINS AND COMPOSITIONS THEREOF - The present publication relates to a vacuum-sealed pack comprising an amorphous statin or a pharmaceutical composition thereof and at least one stabilizer such as, for example, an oxygen absorber, a moisture absorber or a combination thereof. | 03-19-2009 |
20090130210 | PHARMACEUTICAL COMPOSITIONS OF SIROLIMUS - A pharmaceutical composition of sirolimus comprising an inert core and a sugar overcoat, wherein said sugar overcoat comprises sirolimus, a poloxamer other than poloxamer 188, microcrystalline cellulose and binder has been developed. | 05-21-2009 |
20090264408 | EXTENDED RELEASE DOSAGE FORMS OF QUETIAPINE - The present invention relates to an extended release dosage form of quetiapine wherein the dosage form comprises quetiapine and rate-controlling polymer selected from polyethylene oxide, sodium alginate and natural gum and combinations thereof. The dosage form may additionally comprise at least one water-insoluble polymer. | 10-22-2009 |
20100099776 | OILY SUSPENSION OF ATOVAQUONE - The present invention relates to an oily suspension of atovaquone comprising atovaquone particles and a combination of surfactants having HLB more than 10. | 04-22-2010 |
20100178338 | STABILIZED PHARMACEUTICAL COMPOSITIONS COMPRISING ATORVASTATIN - This invention relates to stabilized pharmaceutical compositions comprising atorvastatin or pharmaceutically acceptable salts thereof, and processes for the preparation of the same. | 07-15-2010 |
20100247646 | EXTENDED RELEASE TABLETS OF NISOLDIPINE - The present invention relates to extended release tablets comprising a core which comprises of nisoldipine, a rate-controlling hydrophilic polymer and optionally, an enteric agent. Such tablets may also be coated with a release rate-controlling coating comprising of a hydrophobic polymer or enteric agent or combinations thereof, in particular ethylcellulose, and Eudragits. | 09-30-2010 |
20100297195 | CONTROLLED RELEASE LAMOTRIGINE FORMULATIONS - The present invention relates to controlled release formulations comprising lamotrigine and process for preparation thereof. | 11-25-2010 |
20110052686 | MODIFIED RELEASE LAMOTRIGINE TABLETS - The present invention relates to uncoated modified-release tablets of lamotrigine and the process for preparation thereof, wherein the tablets comprise a portion of lamotrigine in an admixture with a pH-dependent polymer. | 03-03-2011 |
20110217369 | FENOFIBRATE COMPOSITIONS - The present invention relates to a fenofibrate composition comprising: fenofibrate, a surfactant, a hydrophilic polymer and one or more anti-foaming agents. The invention also relates to a novel process for preparing said composition that has enhanced dissolution and absorption characteristics. | 09-08-2011 |
20110217373 | EXTENDED RELEASE PHARMACEUTICAL COMPOSITIONS OF GUANFACINE HYDROCHLORIDE - The present invention relates to an extended release pharmaceutical tablet composition comprising guanfacine comprising: a core containing guanfacine or a pharmaceutically acceptable salt thereof and one or more of pH-independent rate controlling polymer(s) and other pharmaceutically acceptable excipients; optionally a coating over the core as in (a) wherein, the coating comprises one or more of pH-independent rate controlling polymer(s). | 09-08-2011 |
20110218216 | EXTENDED RELEASE PHARMACEUTICAL COMPOSITION OF DONEPEZIL - The present invention relates to an extended release pharmaceutical composition for oral administration comprising donepezil or pharmaceutically acceptable salt thereof and a release-controlling agent. Further, it relates to process for preparation of said compositions. | 09-08-2011 |
20120288532 | MULTI-LAYERED, MULTIPLE UNIT PHARMACEUTICAL COMPOSITIONS - The invention relates to pharmaceutical compositions comprising multilayered multiple units and processes for the preparation thereof. | 11-15-2012 |
20120329831 | PHARMACEUTICAL COMPOSITION OF DONEPEZIL - The present invention relates to a pharmaceutical composition of donepezil or pharmaceutically acceptable salts thereof comprising ethyl cellulose and methacrylic acid copolymer in a ratio of more than 1.3. Further, it relates to process for preparation of said composition. | 12-27-2012 |
20130129827 | EXTENDED RELEASE PHARMACEUTICAL COMPOSITIONS OF PALIPERIDONE AND PROCESSES OF PREPARATION THEREOF - The present invention relates to extended release pharmaceutical compositions of paliperidone and process of preparation thereof. | 05-23-2013 |
20130195973 | EXTENDED RELEASE PHARMACEUTICAL DOSAGE FORMS OF CARBIDOPA AND LEVODOPA AND PROCESS OF PREPARATION THEREOF - The present invention relates to an extended-release pharmaceutical dosage form of carbidopa and levodopa comprising (i) an immediate-release unit of carbidopa and levodopa; (ii) an extended-release unit of carbidopa and levodopa; and (iii) an immediate or extended-release unit of a carboxylate salt. The present invention further provides a process of preparation thereof. | 08-01-2013 |
20130251793 | PHARMACEUTICAL COMPOSITION COMPRISING PHENTERMINE AND TOPIRAMATE - This invention relates to a pharmaceutical composition comprising a combination of phentermine in an immediate-release form and topiramate in an extended-release form. Further, it relates to processes for the preparation of the composition and a method of using the composition. | 09-26-2013 |
20130251795 | PHARMACEUTICAL COMPOSITIONS CONTAINING A BIGUANIDE AND A LOW DOSE ANTIDIABETIC AGENT - The present invention relates to pharmaceutical compositions that include a combination of a biguanide present in an extended-release form and a low dose antidiabetic agent present in an immediate-release form. The present invention further relates to processes for preparing such compositions. | 09-26-2013 |
20140112995 | MULTI-LAYERED, MULTIPLE UNIT PHARMACEUTICAL COMPOSITIONS - The present invention relates to pharmaceutical compositions comprising multilayered multiple units and processes for the preparation thereof. | 04-24-2014 |
20140271846 | GASTRORETENTIVE DOSAGE SYSTEM AND PROCESS OF PREPARATION THEREOF - The present invention relates to novel gastroretentive dosage systems, in particular, a floating capsule which releases the drug without any lag time and which remains buoyant for a sufficient period of time in the stomach. Further, the invention relates to the process of preparation thereof. | 09-18-2014 |
20140377347 | IN-SITU MULTILAYERED TABLET TECHNOLOGY - The present invention relates to an in-situ multilayered tablet comprising at least one polymer layers and at least one drug layers wherein the said layers are physically separated from each other. After coming in contact with biological and/or aqueous fluids at least one of the polymer layers rapidly swells and sticks to one or more drug layers to form an in-situ multilayered tablet. Further, the polymer layer may optionally comprise a drug. Furthermore, the present invention relates to the processes for preparing said in-situ multilayered tablets. | 12-25-2014 |
20140378545 | PREGABALIN GR TABLETS - The present invention relates to a gastroretentive tablet comprising pregabalin, an acrylic acid polymer, one or more swellable polymers, and other pharmaceutically acceptable excipients. It further relates to a process for the preparation of same. | 12-25-2014 |
20150025146 | GASTRORETENTIVE TABLETS - The present invention relates to a gastroretentive tablet comprising pregabalin, at least one swellable polymer, and other pharmaceutically acceptable excipients. It further relates to a process for the preparation of same. | 01-22-2015 |